Antimuscarinics for the treatment of overactive bladder: A review of central nervous system effects

citation_journal_title=Neurourol Urodyn; citation_title=The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society; citation_author=P. Abrams, L. Cardozo, M. Fall; citation_volume=21; citation_publication_date=2002; citation_pages=167-178; citation_doi=10.1002/nau.10052; citation_id=CR1 citation_journal_title=Eur Urol; citation_title=Prevalence of the overactive bladder syndrome by applying the International Continence Society definition; citation_author=C. Temml, S. Heidler, A. Ponholzer, S. Madersbacher; citation_volume=48; citation_publication_date=2005; citation_pages=622-627; citation_doi=10.1016/j.eururo.2005.04.026; citation_id=CR2 citation_journal_title=World J Urol; citation_title=Prevalence and burden of overactive bladder in the United States; citation_author=W.F. Stewart, J.B. Rooyen, G.W. Cundiff; citation_volume=20; citation_publication_date=2003; citation_pages=327-336; citation_id=CR3 citation_journal_title=BJU Int; citation_title=The impact on health-related quality of life of stress, urge and mixed urinary incontinence; citation_author=K.S. Coyne, Z. Zhou, C. Thompson, E. Versi; citation_volume=92; citation_publication_date=2003; citation_pages=731-735; citation_doi=10.1046/j.1464-410X.2003.04463.x; citation_id=CR4 citation_journal_title=Pharmacotherapy; citation_title=Costs associated with the management of overactive bladder and related comorbidities; citation_author=T. Darkow, C.L. Fontes, T.E. Williamson; citation_volume=25; citation_publication_date=2005; citation_pages=511-519; citation_doi=10.1592/phco.25.4.511.61033; citation_id=CR5 Nabi G, Cody JD, Ellis G, et al.: Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. Cochrane Database Syst Rev 2006, CD003781. Sanctura (trospium chloride) 20 mg tablets prescribing information. Available at http://www.sanctura.com/pdf/sanctura_pi.pdf . Accessed February 1, 2007. Detrol LA tolterodine tartrate extended release capsules: prescribing information. Available at http://www.detrolla.com/cwpb/appmanager/detrolLA/detrolLADesktop?_nfpb=true&_pageLabel=detrolLA_prescribingInformation . Accessed February 1, 2007. citation_journal_title=Eur Urol; citation_title=Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study; citation_author=D.E. Irwin, I. Milsom, S. Hunskaar; citation_volume=50; citation_publication_date=2006; citation_pages=1306-1314; citation_doi=10.1016/j.eururo.2006.09.019; citation_id=CR9 citation_journal_title=Arch Intern Med; citation_title=Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts; citation_author=D.M. Fick, J.W. Cooper, W.E. Wade; citation_volume=163; citation_publication_date=2003; citation_pages=2716-2724; citation_doi=10.1001/archinte.163.22.2716; citation_id=CR10 citation_journal_title=Curr Urol Rep; citation_title=Muscarinic receptors: what we know; citation_author=H.M. Scarpero, R.R. Dmochowski; citation_volume=4; citation_publication_date=2003; citation_pages=421-428; citation_doi=10.1007/s11934-003-0021-3; citation_id=CR11 citation_journal_title=Br J Pharmacol; citation_title=Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder; citation_author=P. Abrams, K.E. Andersson, J.J. Buccafusco; citation_volume=148; citation_publication_date=2006; citation_pages=565-578; citation_doi=10.1038/sj.bjp.0706780; citation_id=CR12 citation_journal_title=Nature; citation_title=Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean; citation_author=M. Yamada, T. Miyakawa, A. Duttaroy; citation_volume=410; citation_publication_date=2001; citation_pages=207-212; citation_doi=10.1038/35065604; citation_id=CR13 citation_journal_title=Eur Urol; citation_title=Darifenacin, an M3 selective receptor antagonist, is an effective and well-tolerated once-daily treatment for overactive bladder; citation_author=F. Haab, L. Stewart, P. Dwyer; citation_volume=45; citation_publication_date=2004; citation_pages=420-429; citation_doi=10.1016/j.eururo.2004.01.008; citation_id=CR14 citation_journal_title=Clin Ther; citation_title=Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT); citation_author=A.D. Garely, J.M. Kaufman, P.K. Sand; citation_volume=28; citation_publication_date=2006; citation_pages=1935-1946; citation_doi=10.1016/j.clinthera.2006.11.010; citation_id=CR15 citation_journal_title=J Urol; citation_title=Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder; citation_author=L. Cardozo, M. Lisec, R. Millard; citation_volume=172; citation_publication_date=2004; citation_pages=1919-1924; citation_doi=10.1097/01.ju.0000140729.07840.16; citation_id=CR16 citation_title=Darifenacin is selective for the human recombinant M3 receptor subtype [abstract 445]; citation_inbook_title=Presented at the International Continence Society annual meeting; citation_publication_date=2002; citation_id=CR17; citation_author=C. Napier; citation_author=P. Gupta; citation_publisher=Heidelberg citation_journal_title=Naunyn Schmiedebergs Arch Pharmacol; citation_title=M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland; citation_author=K. Ikeda, S. Kobayashi, M. Suzuki; citation_volume=366; citation_publication_date=2002; citation_pages=97-103; citation_doi=10.1007/s00210-002-0554-x; citation_id=CR18 citation_journal_title=Mayo Clin Proc; citation_title=Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study; citation_author=R.A. Appell, P. Sand, R. Dmochowski; citation_volume=76; citation_publication_date=2001; citation_pages=358-363; citation_doi=10.4065/76.4.358; citation_id=CR19 citation_journal_title=Urology; citation_title=Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder; citation_author=P. Kerrebroeck, K. Kreder, U. Jonas; citation_volume=57; citation_publication_date=2001; citation_pages=414-421; citation_doi=10.1016/S0090-4295(00)01113-4; citation_id=CR20 citation_journal_title=Eur Urol; citation_title=Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects; citation_author=G. Kay, T. Crook, L. Rekeda; citation_volume=50; citation_publication_date=2006; citation_pages=317-326; citation_doi=10.1016/j.eururo.2006.03.057; citation_id=CR21 citation_journal_title=Urol Res; citation_title=Oxybutynin disrupts learning and memory in the rat passive avoidance response; citation_author=T. Sugiyama, Y.C. Park, T. Kurita; citation_volume=27; citation_publication_date=1999; citation_pages=393-395; citation_doi=10.1007/s002400050169; citation_id=CR22 citation_journal_title=Arch Neurol; citation_title=Tolterodine and memory: dry but forgetful; citation_author=K.B. Womack, K.M. Heilman; citation_volume=60; citation_publication_date=2003; citation_pages=771-773; citation_doi=10.1001/archneur.60.5.771; citation_id=CR23 citation_journal_title=J Clin Pharm Ther; citation_title=In vivo age-related changes in hepatic drug-oxidizing capacity in humans; citation_author=E. Tanaka; citation_volume=23; citation_publication_date=1998; citation_pages=247-255; citation_doi=10.1046/j.1365-2710.1998.00164.x; citation_id=CR24 citation_journal_title=Clin Drug Investig; citation_title=Psychotic disorder induced by oxybutynin: presentation of two cases; citation_author=M. Gulsun, M. Pinar, U. Sabanci; citation_volume=26; citation_publication_date=2006; citation_pages=603-606; citation_doi=10.2165/00044011-200626100-00007; citation_id=CR25 citation_journal_title=N Engl J Med; citation_title=Transient memory impairment and hallucinations associated with tolterodine use; citation_author=J.W. Tsao, K.M. Heilman; citation_volume=349; citation_publication_date=2003; citation_pages=2274-2275; citation_doi=10.1056/NEJM200312043492325; citation_id=CR26 citation_journal_title=J Neurosci; citation_title=Nicotinic acetylcholine receptors interact with dopamine in induction of striatal long-term depression; citation_author=J.G. Partridge, S. Apparsundaram, G.A. Gerhardt; citation_volume=22; citation_publication_date=2002; citation_pages=2541-2549; citation_id=CR27 citation_journal_title=J Clin Pharmacol; citation_title=Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system; citation_author=A. Todorova, B. Vonderheid-Guth, W. Dimpfel; citation_volume=41; citation_publication_date=2001; citation_pages=636-644; citation_doi=10.1177/00912700122010528; citation_id=CR28 Once-a-day Ditropan XL (oxybutynin chloride) extended-release tablets 5, 10, 15 mg. Full U.S. prescribing information. Available at http://www.ditropanxl.com/html/pdxl/prescribing_consumer.jsp;jsessionid=UYLZTKGIQK2EOCQPCCFTC0YKB2IIQNSC ? Accessed February 1, 2007. citation_journal_title=World J Urol; citation_title=Transdermal oxybutynin in the treatment of adults with overactive bladder: combined results of two randomized clinical trials; citation_author=R.R. Dmochowski, V. Nitti, D. Staskin; citation_volume=23; citation_publication_date=2005; citation_pages=263-270; citation_doi=10.1007/s00345-005-0012-8; citation_id=CR30 Enablex (darifenacin) extended release tablets: prescribing information. Available at http://www.enablex.com/info/tools/pi.jsp . Accessed February 1, 2007. VESIcare (solifenacin succinate) tablets. Available at http://www.astellas.us/docs/vesicare.pdf . Accessed February 1, 2007. citation_journal_title=Clin Drug Investig; citation_title=Randomized, double-blind study of the effects of oxybutynin, tolterodine, trospium chloride and placebo on sleep in heathy young volunteers; citation_author=K. Diefenback, F. Donath, A. Maurer; citation_volume=23; citation_publication_date=2003; citation_pages=395-404; citation_doi=10.2165/00044011-200323060-00003; citation_id=CR33 citation_journal_title=BMJ; citation_title=Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study; citation_author=M.L. Ancelin, S. Artero, F. Portet; citation_volume=332; citation_publication_date=2006; citation_pages=455-459; citation_doi=10.1136/bmj.38740.439664.DE; citation_id=CR34 citation_journal_title=Acta Neurochir (Wien); citation_title=Influence of aging on blood-brain barrier permeability and free radical formation following experimental brain cold injury; citation_author=P. Erdincler, S. Tuzgen, U.D. Erdincler; citation_volume=144; citation_publication_date=2002; citation_pages=195-199; citation_doi=10.1007/s007010200024; citation_id=CR35 citation_journal_title=Neurobiol Dis; citation_title=Disruption of the blood-brain barrier and neuronal cell death in cingulate cortex, dentate gyrus, thalamus, and hypothalamus in a rat model of Gulf-War syndrome; citation_author=A. Abdel-Rahman, A.K. Shetty, M.B. Abou-Donia; citation_volume=10; citation_publication_date=2002; citation_pages=306-326; citation_doi=10.1006/nbdi.2002.0524; citation_id=CR36 citation_journal_title=J Urol; citation_title=The effect of oxybutynin treatment on cognition in children with diurnal incontinence; citation_author=B.R. Sommer, R. O’Hara, N. Askari; citation_volume=173; citation_publication_date=2005; citation_pages=2125-2127; citation_doi=10.1097/01.ju.0000157685.83573.79; citation_id=CR37 citation_journal_title=Lancet; citation_title=Alzheimer’s disease; citation_author=K. Blennow, M.J. Leon, H. Zetterberg; citation_volume=368; citation_publication_date=2006; citation_pages=387-403; citation_doi=10.1016/S0140-6736(06)69113-7; citation_id=CR38 citation_journal_title=Clin Pharmacol Ther; citation_title=Treatment of urinary incontinence with anticholinergics in patients taking cholinesterase inhibitors for dementia; citation_author=E.L. Siegler, M. Reidenberg; citation_volume=75; citation_publication_date=2004; citation_pages=484-488; citation_doi=10.1016/j.clpt.2004.01.015; citation_id=CR39 citation_journal_title=Ann Neurol; citation_title=Increased Alzheimer pathology in Parkinson’s disease related to antimuscarinic drugs; citation_author=E.K. Perry, L. Kilford, A.J. Lees; citation_volume=54; citation_publication_date=2003; citation_pages=235-238; citation_doi=10.1002/ana.10639; citation_id=CR40 citation_journal_title=Neurobiol Dis; citation_title=Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease; citation_author=M. Garcia-Alloza, E.M. Robbins, S.X. Zhang-Nunes; citation_volume=24; citation_publication_date=2006; citation_pages=516-524; citation_doi=10.1016/j.nbd.2006.08.017; citation_id=CR41 citation_journal_title=J Neuropathol Exp Neurol; citation_title=Environmental enrichment exacerbates amyloid plaque formation in a transgenic mouse model of Alzheimer disease; citation_author=J.L. Jankowsky, G. Xu, D. Fromholt; citation_volume=62; citation_publication_date=2003; citation_pages=1220-1227; citation_id=CR42 citation_journal_title=J Urol; citation_title=Does oxybutynin alter amyloid beta peptides in a mouse model of Alzheimer’s Disease; citation_author=A.P. Klausner, S. Fletcher, S.K. Yang; citation_volume=173; citation_publication_date=2005; citation_pages=41; citation_id=CR43 citation_journal_title=J Urol; citation_title=The effect of oxybutynin on plaques, amyloid beta peptides, and behavior in mouse and human cybrid models of Alzheimer’s Disease [abstract]; citation_author=S. Sharma, A.P. Klausher, S. Fletcher; citation_volume=175; citation_publication_date=2006; citation_pages=55; citation_id=CR44 citation_journal_title=Neuroscience; citation_title=Role of hippocampal M2 muscarinic receptors in the estrogen-induced enhancement of working memory; citation_author=J.M. Daniel, J.L. Hulst, C.D. Lee; citation_volume=132; citation_publication_date=2005; citation_pages=57-64; citation_doi=10.1016/j.neuroscience.2005.01.002; citation_id=CR45